dalteparin has been researched along with Lymphoma, T-Cell in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaluza, V | 1 |
| Rao, DS | 1 |
| Said, JW | 1 |
| de Vos, S | 1 |
1 other study available for dalteparin and Lymphoma, T-Cell
| Article | Year |
|---|---|
Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report.
Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; CD3 Complex; CD56 Antigen; DNA, Neoplasm; Enoxapar | 2006 |